Lirum Therapeutics, Inc IPOs Tomorrow, Here’s What You Need To Know

Lirum Therapeutics, Inc (NASDAQ:LRTX) IPO will take place May, 10 on the NASDAQ exchange under the ticker LRTX.…

Lirum Therapeutics, Inc (NASDAQ:LRTX) IPO will take place May, 10 on the NASDAQ exchange under the ticker LRTX.

The company is offering shares at an expected price between $10.00 and $12.00 per share with an insider lock-up period of 180 days ending on November 06, 2024.

See also: Benzinga IPO Calendar

About Lirum Therapeutics, Inc

Lirum Therapeutics, Inc are an innovative, clinical stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways and commercial opportunities

See also: Benzinga’s Most Shorted Stocks

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

OmniLit Acquisition Corp. Signed A Letter Of Intent For A Business Combination With An Affiliate Company; The Target Is An Advanced Manufacturer Of Optics And Photonics Components And Sub-Systems

OmniLit Acquisition Corp. (“OLIT”) a publicly traded optics and photonics focused special purpose acquisition company, signed a letter of intent for a business combination with an affiliate company (the “Target”) that seeks to become a publicly listed company with an estimated Enterprise Value in the range outlined in OLIT’s IPO prospectus.

OLIT

Read More

GCL Asia, A Video Game Publisher & Distributor In Asia, To Go Public Via Merger With RF Acquisition Corp; Expected To Be Listed On Nasdaw Under “GCL”; Proposed Transaction Gives CGL ~$1.2B In Pre-Transaction Equity Value

GCL Asia is a leading video game distribution and publishing group in Asia, with more than 2100 online and offline retail touchpoints for game distribution.GCL has been the exclusive distributor in Asia for 50% of the

RFAC